v3.25.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT - USD ($)
$ in Millions
Total
Class A Common Stock
Additional Paid-in-Capital
Retained Earnings
Treasury Stock, at Cost
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2022   310,600,000        
Beginning balance at Dec. 31, 2022 $ 568 $ 5 $ 5,965 $ 12,342 $ (17,015) $ (729)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 3,083     3,083    
Other comprehensive income (loss) 82         82
Dividends (587)     (587)    
Stock-based compensation plans (in shares)   1,400,000        
Stock-based compensation plans 126   86   40  
Purchase of treasury stock (in shares)   (21,500,000)        
Purchase of treasury stock (3,954)       (3,954)  
Ending balance (in shares) at Dec. 31, 2023   290,500,000        
Ending balance at Dec. 31, 2023 (682) $ 5 6,051 14,838 (20,929) (647)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 2,375     2,375    
Other comprehensive income (loss) (416)         (416)
Dividends (682)     (682)    
Stock-based compensation plans (in shares)   1,600,000        
Stock-based compensation plans 174   128   46  
Purchase of treasury stock (in shares)   (15,400,000)        
Purchase of treasury stock (3,761)       (3,761)  
Ending balance (in shares) at Dec. 31, 2024   276,700,000        
Ending balance at Dec. 31, 2024 (2,992) $ 5 6,179 16,531 (24,644) (1,063)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 2,601     2,601    
Other comprehensive income (loss) 421         421
Dividends (718)     (718)    
Stock-based compensation plans (in shares)   1,300,000        
Stock-based compensation plans 211   173   38  
Purchase of treasury stock (in shares)   (12,100,000)        
Purchase of treasury stock $ (3,294)       (3,294)  
Ending balance (in shares) at Dec. 31, 2025 265,864,771 265,900,000 [1]        
Ending balance at Dec. 31, 2025 $ (3,771) $ 5 $ 6,352 $ 18,414 $ (27,900) $ (642)
[1] Our restated certificate of incorporation authorizes 800,000,000 shares of our common stock, with a par value of $0.01 per share and 10,000,000 shares of preferred stock, without par value. At year-end 2025, we had 265,864,771 of these authorized shares of our common stock and no preferred stock outstanding.